Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01176604 · ClinicalTrials.gov registry record · NA
Yttrium Y 90 Glass Microspheres in Treating Patients With Unresectable Hepatocellular Carcinoma
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 299
- Enrollment target
NCT01176604: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT01176604 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 299 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01176604, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 299 participants
- Enrollment target
Study Summary
This trial studies how well yttrium Y 90 glass microspheres work in treating patients with hepatocellular carcinoma that cannot be removed by surgery. Radioactive drugs, such as yttrium Y 90 glass microspheres, may carry radiation directly to cancer cells and not harm normal cells.
Interventions
- RADIATION Yttrium Y 90 Glass Microspheres
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 299 participants |
| Start Date | 2010-08-04 |
| Est. Completion | 2021-04-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01176604
The ClinicalTrials.gov registry entry for NCT01176604 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 299 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Yttrium Y 90 Glass Microspheres is the first listed.
NCT01176604 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01176604 about?
NCT01176604 is a clinical study titled "Yttrium Y 90 Glass Microspheres in Treating Patients With Unresectable Hepatocellular Carcinoma". This trial studies how well yttrium Y 90 glass microspheres work in treating patients with hepatocellular carcinoma that cannot be removed by surgery. Radioactive drugs, such as yttrium Y 90 glass microspheres, may carry radiation directly to cancer cells and not harm normal cells.
What is the current status of trial NCT01176604?
This trial is currently completed. It is a NA study. The enrollment target is 299 participants. The study started on 2010-08-04. Estimated completion is 2021-04-09.
What interventions are being tested in trial NCT01176604?
The interventions under investigation include: Yttrium Y 90 Glass Microspheres (RADIATION).
Who is sponsoring clinical trial NCT01176604?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.